Daniel E. Geffken

CIK 1314756 · Interim CFO · last filed 2024-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$676.0K

Companies

7

Total Filings

14

Lifetime Open-Market Net

$51.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CALC Interim CFO $0.87 $0 2 2024-05-20
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Chief Financial Officer 10,002 $0.05 $501 $0 1 2024-02-16
PMN Chief Financial Officer $10.35 $0 1 2023-10-30
WINT Director 2,175 $0.01 $31 $15.0K 6 2023-08-29
ELOX INTERIM CFO 50,000 $13.52 $676.0K $36.0K 2 2021-12-01
CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted Chief Financial Officer $10.37 $0 1 2021-10-12
LWACU Chief Financial Officer $10.30 $0 1 2021-01-14

Recent Filings · Page 2 of 2

14 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-05 WINT Grant (A) $0 EDGAR
2021-01-14 LWACU Other (J) $0 EDGAR
2020-05-27 WINT Buy (P) +2,069 $15.0K EDGAR
2019-04-26 WINT Grant (A) $0 EDGAR
Showing 1114 of 14
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.